| Leveraging multi-organ models for drug combination therapy safety | Biomedicine & pharmacotherapy |  | | 2025 | 34 | 89 |
|
| Generation and maintenance of kidney and kidney cancer organoids from patient-derived material for drug development and precision oncology | Molecular therapy. Methods & clinical development | | | 2024 | 64 | 62 |
|
